| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1302607e8c06d652c8d24925df203c7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9ca33b71cfd51739b96ece32919e0e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77efb158eb15ed253fe3bfdc80a16f3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_082f5396e8204ddc8b59a06a66409c25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46203e13bddc67b6f82a501b309cfde0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53cfebbd98f3bd3aa46be8b95ade8174 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2008-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41c8ae0937e44df0cdae030a1dd10664
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a944067eb62fd1cde762598c444c8f5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07a9997aee3f450b77ca3ddd6328ab92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_213cb3024f2277740ef39b27da41be6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c68ab6f6962869b5985290b55d15057f |
| publicationDate |
2009-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009025958-A1 |
| titleOfInvention |
Erythropoietin rceptor peptide formulations and uses |
| abstract |
The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, and dosages are also provided. |
| priorityDate |
2007-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |